A first of its kind: US FDA-approved nasal spray available for treatment-resistant depression in America
Johnson & Johnson reported that Spravato treated over 100,000 patients in 77 countries worldwide, including roughly 80,000 in ...
Verywell Health on MSN1d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Monthly Prescribing Reference5d
Spravato Approved as Monotherapy for Treatment-Resistant Depression
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
MM&M6d
Rx Rundown: AbbVie, Purdue Pharma, HHS and more
The Sackler family, owners of Purdue Pharma, reached a $7.4 billion settlement to resolve mass opioid litigation. The Department of Justice filed a civil lawsuit against Walgreens over allegations it ...
Boing Boing on MSN5d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
pharmaphorum5d
FDA approves Janssen’s ketamine-based nasal antidepressant
Spravato (esketamine ... not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode. It is estimated that approximately ...
ERR News4d
Estonian psychiatrists want to update use of psychedelics in mental health care
A group of Estonian psychiatrists and civic activists believe that allowing the therapeutic use of currently prohibited ...
pharmaphorum2d
Beckley builds case for its psychedelic depression therapy
According to Beckley, BPL-003 achieved an antidepressant response after a single intranasal dose – administered ... in 2019 of Johnson & Johnson’s Spravato (intranasal esketamine) for TRD ...
Managed Healthcare Executive6d
FDA and EMA Accepts Applications for New Nusinersen Regimen
An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines ...
Medical News Today3d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
STAT6d
What science actually tells us about sex and gender
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...